Clinical and Radiological Outcomes of Medacta Shoulder System FR

Launched by MEDACTA INTERNATIONAL SA · Jun 22, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at the Medacta Shoulder System, a type of shoulder replacement surgery, to see how well it works for patients with various shoulder conditions, such as osteoarthritis, rotator cuff tears, and other issues that affect shoulder function. The purpose of this study is to gather more information about how patients do after this surgery, both in terms of their physical health and through imaging tests that check the shoulder's condition.

To participate in this trial, you need to be over 18 years old and have one of the specific shoulder problems mentioned. Unfortunately, if you have cancer, an active infection, or other serious health issues, you won’t be eligible to join. If you do take part, you can expect to receive the Medacta Shoulder System and will be monitored for your recovery and how well the shoulder is functioning afterward. This trial is currently recruiting participants, and it aims to help improve shoulder treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients older than 18 years
• * Patient with one of the following diagnosis:
• • Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty
• Exclusion Criteria:
• • Patients with malignant diseases (at the time of surgery)
• • Patients with proven or suspect infections (at the time of surgery)
• • Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
• • Patients with known incompatibility or allergy to products materials (at the time of surgery)